Asylia Therapeutics

Developer of medicines for cancer, autoimmune, and infectious diseases

placeHouston, Texas, United States calendar_todayFounded 2019 groups4 employees language asyliatx.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace steady. Cited 324 times.

YearFilings
20211
20221
20232
20242
20251

Investor mix

2 investors on record; lead investors include Sporos Bioventures.

Investor typeCountShare
Other / undisclosed2100%
Coming soon